Home Strains Research Conditions Breeders Compare Explorer Blog

Command Palette

Search for a command to run...

BudProfiles

The world's most comprehensive cannabis strain directory, backed by scientific research.

11,121 strains · 12,304 studies · 268 breeders

Effects of the cannabinoid-1 receptor antagonist rimonabant — 2011 Double Blind Clinical Trial | BudProfiles

Home

Studies

Effects of the cannabinoid-1 receptor antagonist r...

NegativeDouble Blind Clinical Trial2011

Effects of the cannabinoid-1 receptor antagonist rimonabant on psychiatric symptoms in overweight people with schizophrenia: a randomized, double-blind, pilot study

View Study

Classification Results

AI Classification

Negative

Fine-tuned Classification

N/A

Conditions Studied

Obesity Schizophrenia

Related Studies

Positive

Caffeine, nicotine, cannabis, and psilocybin: Pharmacology, toxicology, and potential therapeutic uses of four naturally occurring psychoactive substances

2025·Laboratory Study -

Inconclusive

Critical Windows of Vulnerability: Behavioral Dysregulation After Prenatal vs. Adolescent THC Exposure

2025·Review/Other

Inconclusive

Recreational drugs repurposed for medicinal use—cannabis

2025·Review/Other

Inconclusive

Cannabinoid exposure during pregnancy: consequences for growth, memory and prefrontal cortex integrity in Wistar Rats

2025·Animal Study -

Inconclusive

Specific features of cannabidiol metabolism and excretion during long-term consumption of cannabis

2025·Review/Other

Positive

Possible Anxiolytic Effects of Cannabidiol (CBD) Administration on Feline Responses to a Fear Response Test

2025·Animal Study -

Cannabinoids

Pharma THC

Organ Systems

Endocrine SystemMental/Emotional SystemNervous System

Study Details

Type: Double Blind Clinical Trial
Year: 2011
Study ID: #2011009